BU-NOT-SET

CONTACT US
Evolving strategies in oral solid dosage development
  • Drug product
a woman in a laboratory holding a vial
Insight
Sustainable pharmaceutical packaging
  • Sustainability
vials
Case study
Webinar | Bringing High Potent Drugs to Market
  • Drug product
  • Manufacturing
active pharmaceutical ingredient
Webinar
IVPT Strategies for reliable bioequivalence assessment
  • Drug product
  • Manufacturing
lab vials
White paper
Recipharm Advanced Bio Is Advancing Optimizing TFF for RNA
  • Biologics
  • Manufacturing
RNA
White paper
Accelerating an innovative high potency oncology therapy to market
  • Drug product
  • Manufacturing
white powder
Case study
When OSD manufacturing goes global
  • Manufacturing
white pills
Insight
Ensuring Reliable HPAPI Supply
  • Drug product
  • Manufacturing
active pharmaceutical ingredient
Insight
De-risking high-potency programmes
  • Drug product
  • Manufacturing
Recipharm lab
Insight
Insight
  • Manufacturing
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
Brochure
  • Corporate
Recipharm 25 years
Fact sheet
  • Drug substance
API product list
Insight
  • Drug substance
Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes
Insight
  • Industry trends
The demand for antibiotics and its impact on the pharmaceutical industry since the outbreak of COVID-19
Insight
  • Corporate
Women in leadership
Insight
  • Drug product
The state of the oral solid dose development and manufacturing market
Insight
  • Drug substance
Characterising APIs is Essential for Combo Drug Formulations
Insight
  • Analytical chemistry
Outsourcing stability testing